相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis
Simon B. Goldberg et al.
PSYCHIATRY RESEARCH (2020)
Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression
J. B. Stroud et al.
PSYCHOPHARMACOLOGY (2018)
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
R. L. Carhart-Harris et al.
PSYCHOPHARMACOLOGY (2018)
The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act
Matthew W. Johnson et al.
NEUROPHARMACOLOGY (2018)
Treatment resistant depression: A multi-scale, systems biology approach
Huda Akil et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2018)
More Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant Depression
Taylor Lyons et al.
FRONTIERS IN PSYCHOLOGY (2018)
Psychedelics as Medicines: An Emerging New Paradigm
D. E. Nichols et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Distress
Thomas C. Swift et al.
JOURNAL OF HUMANISTIC PSYCHOLOGY (2017)
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Roland R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
Stephen Ross et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Association of Breast Cancer Knowledge With Receipt of Guideline-Recommended Breast Cancer Treatment
Rachel A. Freedman et al.
JOURNAL OF ONCOLOGY PRACTICE (2016)
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
Robin L. Carhart-Harris et al.
LANCET PSYCHIATRY (2016)
Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers
Rainer Kraehenmann et al.
BIOLOGICAL PSYCHIATRY (2015)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
David Moher et al.
SYSTEMATIC REVIEWS (2015)
Psilocybin - Summary of knowledge and new perspectives
Filip Tyls et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
Treatment-resistant depression: Definitions, review of the evidence, and algorithmic approach
Roger S. McIntyre et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
Prediction of Psilocybin Response in Healthy Volunteers
Erich Studerus et al.
PLOS ONE (2012)
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
Robin L. Carhart-Harris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Hallucinogen-persisting perception disorder
Leo Hermle et al.
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2012)
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Charles S. Grob et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies
Erich Studerus et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Depression and cancer mortality: a meta-analysis
M. Pinquart et al.
PSYCHOLOGICAL MEDICINE (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
ANNALS OF INTERNAL MEDICINE (2009)
Human hallucinogen research: guidelines for safety
M. W. Johnson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Opinion - Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms
Robert J. DeRubeis et al.
NATURE REVIEWS NEUROSCIENCE (2008)
Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients
Mogens Groenvold et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study
F Hasler et al.
PSYCHOPHARMACOLOGY (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
The pharmacology of psilocybin
T Passie et al.
ADDICTION BIOLOGY (2002)
Higher expression of serotonin 5-HT2A receptors in the postmortem brains of teenage suicide victims
GN Pandey et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
The changeable nature of patients' fears regarding chemotherapy: Implications for palliative care
SD Passik et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2001)
Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer
W Breitbart et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
分享论文
